Retinal venular caliber predicts visual outcome after intravitreal ranibizumab injection treatments for neovascular AMD.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1167/iovs.11-7689PMID 22110075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retinal Vascular Caliber and Brachial Flow-Mediated Dilation: The Multi-Ethnic Study of Atherosclerosis

  2010cited by this paper
• Meta-analysis: Retinal Vessel Caliber and Risk for Coronary Heart Disease

  2009cited by this paper
• WITHDRAWN: One Year Results of the Effect of Intravitreal Ranibizumab on the Retinal Arteriolar Diameter in Patients with Neovascular Age-Related Macular Degeneration.

  2009cited by this paper
• Retinal vascular caliber: systemic, environmental, and genetic associations.

  2009cited by this paper
• Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.

  2009cited by this paper
• Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis.

  2009cited by this paper
• Retinal vascular caliber and age-related macular degeneration: the Singapore Malay Eye Study.

  2008cited by this paper
• Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.

  2008cited by this paper
• Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study.

  2008cited by this paper
• Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results.

  2007influential reference
• An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.

  2007cited by this paper
• Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration.

  2007influential reference
• Intravitreous injections

  2006cited by this paper
• Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

  2006cited by this paper
• Ranibizumab in neovascular age-related macular degeneration

  2006cited by this paper
• Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA).

  2006influential reference
• Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study.

  2006cited by this paper
• Ranibizumab for neovascular age-related macular degeneration.

  2006cited by this paper
• Correction of optic disc measurements on fundus photographs

  2004cited by this paper
• EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS

  2004cited by this paper
• Revised formulas for summarizing retinal vessel diameters

  2003cited by this paper
• Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.

  2002cited by this paper
• Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes.

  2002cited by this paper
• Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.

  2001cited by this paper
• Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor.

  2000cited by this paper
• Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study.

  1999cited by this paper
• Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.

  1996cited by this paper
• Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes.

  1996influential reference

• Retinal Vessel Traits and Age‐Related Eye Disease in the Canadian Longitudinal Study on Aging

  2025cites this paper
• Retinal vascular structure independently predicts the initial treatment response in neovascular age‐related macular degeneration

  2023cites this paper
• Retinal metabolic and structural alterations in response to aflibercept treatment in neovascular age‐related macular degeneration

  2018cites this paper
• One‐Year Effectiveness Study of Intravitreous Ranibizumab in Wet (Neovascular) Age‐Related Macular Degeneration: A Meta‐Analysis

  2018cites this paper
• Review of the association between retinal microvascular characteristics and eye disease

  2018influential citation
• Retinal metabolic and structural alterations in response to aflibercept treatment in neovascular age-related macular degeneration

  2018cites this paper
• Retinal Vessel Caliber Measurement Using MultiColor and Infrared Confocal Scanning Laser Ophthalmoscopy Fundus Images

  2016cites this paper
• Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment

  2016cites this paper
• Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD

  2016cites this paper
• The clinical implications of recent studies on the structure and function of the retinal microvasculature in diabetes

  2015cites this paper
• Association of retinal vessel calibre and visual outcome in eyes with diabetic macular oedema treated with ranibizumab

  2014cites this paper
• Retinal Vascular Imaging in Clinical Research

  2014cites this paper
• Vision Rehabilitation in Patients with Age-related Macular Degeneration

  2014cites this paper
• Childhood Vascular Risk Factors and Retinal Vessel Caliber

  2012cites this paper
• Clinical Ophthalmology Dovepress the Effects of Ranibizumab Injections on Fluorescein Angiographic Findings and Visual Acuity Recovery in Age-related Macular Degeneration

  year unknowncites this paper